Using Telehealth to Enhance Oral Health for Cancer Survivors

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial evaluates the effectiveness of a Telehealth Intervention (THI) aimed at preventing oral complications and improving oral health among cancer survivors. Participants will be randomly assigned to receive either the THI or Usual Care (UC) over a six-month period. The study will assess oral health outcomes, quality of life, and systemic inflammation through intraoral imaging and saliva sample analysis. A total of 100 cancer survivors will be recruited for this study, with a focus on those who are at least six months post-treatment.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* male and female cancer survivors who are either ≥ 6 months after competing primary therapy for cancer treatment (N=100)
* between 25-75 years of age
* all race/ethnic groups
* own a smart phone.

Exclusion Criteria:

* all head and neck/oral cancer survivors
* less then 25 years and older than 75 years of age
* recurrence/second cancers or undergoing treatment
* unable to provide informed consent.

Where it's running

• Georgetown Lombardi Office of Minority Health
  Washington D.C., District of Columbia, United States Recruiting

Study contacts

• Study coordinator: Smith
• Email: ds1924@georgetown.edu
• Phone: 202-687-5367

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Effect of Periodontal Therapy on Gut Microbes and Inflammation in People with Inflammatory Bowel Disease

  This study tests whether treating gum disease in people with inflammatory bowel disease can influence the gut microbiome and markers of systemic inflammation.

  Recruiting University of Turin, Italy · Turin, Turin · NCT07905859

• Copaiba Mouthwash with Low-Level Laser Therapy to Prevent Mouth Sores After Stem Cell Transplant

  This phase 2 trial tests whether a copaíba-based mouthwash, used four times daily, can help prevent oral mucositis in patients undergoing autologous hematopoietic stem cell transplantation.

  Recruiting Phase 2 Instituto Nacional de Cancer, Brazil · Rio de Janeiro, Rio de Janeiro · NCT07810530

• Bacterial Diversity in Gum Health With Fixed vs Removable Retainers After Braces

  This study tests the gum microbiome and gum health in adults after braces, comparing fixed lingual retainers to removable Essix retainers.

  Recruiting Universidad de Murcia · Murcia · NCT07718061

• Chlorophyllin to reduce mouth sores before allogeneic stem cell transplant

  This phase II study tests whether taking chlorophyllin by mouth can lower the chances and severity of mouth ulcers in patients aged 12–65 undergoing radiation-based conditioning before a first allogeneic stem cell transplant.

  Recruiting Phase 2 Tata Memorial Centre · Navi Mumbai, Maharashtra · NCT07709195

• BupiZenge vs Lidocaine for mouth pain from oral mucositis in head and neck cancer

  A phase 3 trial tests whether the BupiZenge lozenge provides better pain relief than lidocaine for mouth sores caused by radiation in head and neck cancer patients.

  Recruiting at 9 sites Phase 3 OncoZenge AB · Copenhagen and 10 other locations · NCT07672236

• Hyperuricemia and gum disease: is uric acid linked to bone loss in periodontitis?

  This observational study tests whether high uric acid levels are related to periodontitis and alveolar bone loss in adults.

  Recruiting Recep Tayyip Erdogan University Training and Research Hospital · Rize · NCT07666126

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.